HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Treatment and long-term follow-up of patients with stage II to III idiopathic membranous nephropathy.

Abstract
Many important aspects of the therapeutic approach to patients with idiopathic membranous nephropathy are still controversial. There are several reports that the effectiveness of therapy depends on histological staging and severity of interstitial mononuclear cell infiltration. We used several different treatments in 39 patients with stage II to III primary membranous nephropathy with proteinuria more than 2.5 g/d, without hypertension and chronic renal failure at biopsy. Ten patients were not treated, 13 were treated with only steroids, 13 with alternate use of steroids and chlorambucil, and three with cyclosporine A. The follow-up period was 5 to 10 years. Statistics included Kruskall-Wallis and one-way ANOVA analysis. A significant decrease in proteinuria was noted in patients treated with steroids (P < 0.01), from 8.45 +/- 1.04 g/d (mean +/- SEM) to 1. 42 +/- 0.45 g/d after follow-up of 5 years and in patients treated with steroids and chlorambucil (12.9 +/- 2.4 g/d [mean +/- SEM] to 2. 46 +/- 1.38 g/d). Compared with patients treated with steroids (15. 3%) and patients treated with steroids and chlorambucil (15.3%), untreated patients had a high frequency of chronic renal failure after 5 years of follow-up (70%) and had a significant increase in mean serum creatinine (P = 0.008). We conclude that steroid therapy alone, or associated with chlorambucil, is effective in patients with stage II to III membranous nephropathy. Patients responded with a decrease of proteinuria and stable renal function during the long-term follow-up period. The group of patients treated with cyclosporine A was too small to analyze.
AuthorsM H Polenakovik, L Grcevska
JournalAmerican journal of kidney diseases : the official journal of the National Kidney Foundation (Am J Kidney Dis) Vol. 34 Issue 5 Pg. 911-7 (Nov 1999) ISSN: 0272-6386 [Print] United States
PMID10561149 (Publication Type: Comparative Study, Journal Article)
Chemical References
  • Chlorambucil
  • Cyclosporine
  • Prednisolone
  • Methylprednisolone
Topics
  • Adult
  • Chlorambucil (administration & dosage, adverse effects)
  • Cyclosporine (administration & dosage, adverse effects)
  • Drug Administration Schedule
  • Drug Therapy, Combination
  • Female
  • Glomerulonephritis, Membranous (classification, drug therapy, pathology)
  • Humans
  • Kidney Function Tests
  • Kidney Glomerulus (drug effects, pathology)
  • Male
  • Methylprednisolone (administration & dosage, adverse effects)
  • Middle Aged
  • Prednisolone (administration & dosage, adverse effects)
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: